Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Decision Making: P-value Method
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Pharmacokinetic Models: Comparison and Selection Criterion
Quantifying and Rejecting Outliers: The Grubbs Test
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Nov 17, 2025

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
Y-Ling Chi1, Mark Blecher2, Kalipso Chalkidou1,3
1Center for Global Development, London, SW1P 3SE, UK.
Public payers use cost-effectiveness thresholds (CETs) for healthcare coverage decisions. This study offers five practical alternatives to the criticized 1-3 GDP per capita rule for low- and middle-income countries seeking Universal Health Coverage.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: